Surgical site infection associated with the use of bovine serum albumine-glutaraldehyde surgical adhesive (BioGlue®) in cranial surgery: A case-control study

Acta Neurochirurgica

Volumn 153, Issue 1, 2011, Pages 156-162

  Gaberel, Thomas ^a   Borgey, France ^a   Thibon, Pascal ^a   Lesteven, Claire ^a   Lecoutour, Xavier ^a   Emery, Evelyne ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

BioGlue; Craniotomy; Dural sealant; Dural substitute; NeuroPatch; Surgical wound infection

Indexed keywords

BIOGLUE; GLUE; NEUROPATCH; TISSUE ADHESIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CASE CONTROL STUDY; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CRANIOTOMY; FEMALE; HUMAN; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPIONIBACTERIUM; RISK ASSESSMENT; RISK FACTOR; SKULL SURGERY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION;

ADULT; AGED; ANIMALS; CASE-CONTROL STUDIES; CATTLE; CRANIOTOMY; DURA MATER; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEINS; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TISSUE ADHESIVES;

EID: 78651261184     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-010-0830-3     Document Type: Article

References (28)

1. P Cappabianca F Esposito F Magro LM Cavallo D Solari L Stella O de Divitiis 2010 Natura abhorret a vacuo-use of fibrin glue as a filler and sealant in neurosurgical "dead spaces". Technical note Acta Neurochir (Wien) 152 5 897 904 10.1007/s00701-009-0580-2
2. AB Cronquist K Jakob L Lai P Della Latta EL Larson 2001 Relationship between skin microbial counts and surgical site infection after neurosurgery Clin Infect Dis 33 8 1302 1308 1:STN:280:DC%2BD3MrhslalsQ%3D%3D 10.1086/322661 11565069 (Pubitemid 32955178)
3. JR Dusick CA Mattozo F Esposito DF Kelly 2006 BioGlue for prevention of postoperative cerebrospinal fluid leaks in transsphenoidal surgery: a case series Surg Neurol 66 4 371 376 10.1016/j.surneu.2006.06.043 17015111 (Pubitemid 44466096)
4. AW Erasmi HH Sievers 2002 Inflammatory response after BioGlue application (letter) Ann Thorac Surg 73 1020 1028 10.1016/S0003-4975(01)03524-X
5. T Erman H Demirhindi AI Göçer M Tuna F Ildan B Boyar 2005 Risk factors for surgical site infections in neurosurgery patients with antibiotic prophylaxis Surg Neurol 63 2 107 112 10.1016/j.surneu.2004.04.024 15680644 (Pubitemid 40174889)
6. W Fürst A Banerjee 2005 Release of glutaraldehyde from an albumin-glutaraldehyde tissue adhesive causes significant in vitro and in vivo toxicity Ann Thorac Surg 79 5 1522 1528 10.1016/j.athoracsur.2004.11.054 15854927 (Pubitemid 40614559)
7. Gaffen A, Zheng H (2006) BioGlue Surgical Adhesive: reported incidents of chronic inflammation and foreign-body reactions. Can Adverse React Newsl 16(4)
8. S Gruber-Blum AH Petter-Puchner K Mika, et al. 2010 A comparison of a bovine albumin/glutaraldehyde glue versus fibrin sealant for hernia mesh fixation in experimental onlay and IPOM repair in rats Surg Endosc. 10.1007/s00464-010-1094-y 20512511
9. GW Herget UN Riede M Kassa L Brethner J Hasse 2003 Experimental use of an albumin-glutaraldehyde tissue adhesive for sealing tracheal anastomoses J Cardiovasc Surg (Torino) 44 1 109 113 1:STN:280:DC%2BD3s7htlGnug%3D%3D
10. CW Hewitt SW Marra BR Kann, et al. 2001 BioGlue surgical adhesive for thoracic aortic repair during coagulopathy: efficacy and histopathology Ann Thorac Surg 71 5 1609 1612 1:STN:280:DC%2BD3MzhtVersA%3D%3D 10.1016/S0003- 4975(01)02424-9 11383808 (Pubitemid 32452551)
11. A Kassam M Horowitz R Carrau C Snyderman W Welch B Hirsch YF Chang 2003 Use of Tisseel fibrin sealant in neurosurgical procedures: incidence of cerebrospinal fluid leaks and cost-benefit analysis in a retrospective study Neurosurgery 52 1102 1105 10.1227/01.NEU.0000057699.37541.76 12699553
12. P Klimo Jr A Khalil JR Slotkin ER Smith RM Scott LC Goumnerova 2007 Wound complications associated with the use of bovine serum albumin-glutaraldehyde surgical adhesive in pediatric patients Neurosurgery 60 4 Suppl 2 305 309 17415167
13. AM Korinek 1997 Risk factors for neurosurgical site infections after craniotomy: a prospective multicenter study of 2944 patients. The French Study Group of Neurosurgical Infections, the SEHP, and the C-CLIN Paris-Nord. Service Epidémiologie Hygiène et Prévention Neurosurgery 41 5 1073 1079 1:STN:280:DyaK1c%2Fis12itw%3D%3D 10.1097/00006123-199711000-00010 9361061 (Pubitemid 27475468)
14. AM Korinek JL Golmard A Elcheick 2005 Risk factors for neurosurgical site infections after craniotomy: a critical reappraisal of antibiotic prophylaxis on 4, 578 patients Br J Neurosurg 19 2 155 162 10.1080/02688690500145639 16120519
15. A Kumar NF Maartens AH Kaye 2003 Evaluation of the use of BioGlue in neurosurgical procedures J Clin Neurosci 10 6 661 664 1:CAS:528: DC%2BD3sXosVynsbw%3D 10.1016/S0967-5868(03)00163-2 14592612 (Pubitemid 37408625)
16. A Kumar NF Maartens AH Kaye 2003 Reconstruction of the sellar floor using BioGlue following transsphenoidal procedures J Clin Neurosci 10 1 92 95 10.1016/S0967-5868(02)00262-X 12464532 (Pubitemid 35453257)
17. SA Lemaire LN Ochoa LD Conklin, et al. 2007 Nerve and conduction tissue injury caused by contact with BioGlue J Surg Res 143 2 286 293 1:CAS:528:DC%2BD2sXhtlalsb3F 10.1016/j.jss.2006.10.014 17765925 (Pubitemid 350101556)
18. C Lietard V Thébaud G Besson B Lejeune 2008 Risk factors for neurosurgical site infections: an 18-month prospective survey J Neurosurg 109 4 729 734 10.3171/JNS/2008/109/10/0729 18826362
19. M Malliti P Page C Gury E Chomette F Nataf FX Roux 2004 Comparison of deep wound infection rates using a synthetic dural substitute (neuro-patch) or pericranium graft for dural closure: a clinical review of 1 year Neurosurgery 54 3 599 603 10.1227/01.NEU.0000108640.45371.1A 15028133
20. HD Mollman SJ Haines 1986 Risk factors for postoperative neurosurgical wound infection. A case-control study J Neurosurg 64 6 902 906 1:STN:280:DyaL287pvV2nsg%3D%3D 10.3171/jns.1986.64.6.0902 3701440
21. DL Ngaage WD Edwards MR Bell TM Sundt 2005 A cautionary note regarding long-term sequelae of biologic glue J Thorac Cardiovasc Surg 129 4 937 938 10.1016/j.jtcvs.2004.07.046 15821668 (Pubitemid 40487902)
22. JS Raul F Arbez-Gindre A Czorny 2003 Use of polyester urethane (Neuro-Patch®) as a dural substitute. Prospective study of 70 cases (French) Neurochirurgie 49 2-3 Pt 1 83 89 12746723
23. W Schiller H Rudorf MJ Kiderlen, et al. 2007 Short-term tissue response of lapine carotid artery microanastomoses to BioGlue Thorac Cardiovasc Surg 55 5 298 303 1:STN:280:DC%2BD2svht1eqtw%3D%3D 10.1055/s-2007-965282 17629859 (Pubitemid 47356192)
24. A Sen KM Green MI Khan SR Saeed RT Ramsden 2006 Cerebrospinal fluid leak rate after the use of BioGlue® in translabyrinthine vestibular schwannoma surgery: a prospective study OtolNeurotol 27 1 102 105
25. SS Stylli A Kumar M Gonzales AH Kaye 2004 The biocompatibility of BioGlue with the cerebral cortex: a pilot study J Clin Neurosci 11 6 631 635 1:CAS:528:DC%2BD2cXlslOqtb0%3D 10.1016/j.jocn.2004.03.018 15261237 (Pubitemid 38916976)
26. P Taflampas E Sanidas M Christodoulakis J Askoxylakis J Melissas DD Tsiftsis 2009 Sealants after axillary lymph node dissection for breast cancer: good intentions but bad results Am J Surg 198 1 55 58 10.1016/j.amjsurg.2008.06. 043 19217598
27. S Westaby S Saito T Katsumata 2002 Acute type A dissection: conservative methods provide consistency low mortality Ann Thorac Surg 73 707 713 10.1016/S0003-4975(01)03449-X 11899170 (Pubitemid 34188300)
28. T Yuen AH Kaye 2005 Persistence of Bioglue in spinal dural repair J Clin Neurosci 12 1 100 101 10.1016/j.jocn.2004.06.006 15639428 (Pubitemid 40082637)